Практичні настанови Європейської асоціації клінічного харчування та метаболізму (ESPEN). Клінічне харчування при захворюваннях печінки

Автор(и)

  • S. C. Bischoff Гогенгаймський університет, Штутгарт
  • W. Bernal Інститут досліджень печінки, лікарня Кінгз-Коледж, Лондон
  • S. Dasarathy Клівлендська клініка, Огайо
  • M. Merli Римський університет ла Сап’єнца
  • L. D. Plank Оклендський університет
  • T. Schütz Інтегрований науково-лікувальний центр захворювань ожиріння, Медичний центр Лейпцизького університету
  • M. Plauth Муніципальна лікарня Дессау
  • І. Скрипник Українська гастроентерологічна асоціація, Полтава
  • O. Швець Асоціація дієтологів України, Київ

DOI:

https://doi.org/10.30978/MG-2021-1-59

Ключові слова:

мальнутриція, саркопенія, гостра печінкова недостатність, жирова хвороба печінки, алкогольний стеатогепатит, цироз, трансплантація, хірургія

Анотація

Практичні настанови ґрунтуються на чинних Наукових настановах ESPEN з клінічного харчування при захворюваннях печінки (Plauth M., Bernal W., Dasarathy S., Merli M., Plank L. D., Schütz T., Bischoff S. C. ESPEN guideline on clinical nutrition in liver disease // Clin Nutr. — 2019. — 38. — Р. 485—521). Їх було скорочено та перетворено на блок‑схеми для зручнішого використання в клінічній практиці.

Настанови призначені для професіоналів (лікарів, дієтологів, нутриціологів та медичних сестер), які працюють з пацієнтами з хронічними захворюваннями печінки. Загалом представлено 103 твердження та рекомендації з короткими коментарями щодо харчового та метаболічного ведення пацієнтів з: 1) гострою печінковою недостатністю, 2) алкогольним стеатогепатитом, 3) неалкогольною жировою хворобою печінки, 4) цирозом печінки, 5) після операції/трансплантації печінки. Рекомендаціям, пов’язаним із захворюванням, передують загальні рекомендації щодо діагностики стану харчування пацієнтів із захворюваннями печінки та ускладнень, пов’язаних з лікувальним харчуванням.

Посилання

Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38 : 485-521.

Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T et al. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020.

Bischoff SC, Singer P, Koller M, Barazzoni R, Cederholm T, van Gossum A. Standard operating procedures for ESPEN guidelines and consensus papers. Clin Nutr. 2015;34 : 1043-51.

Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22 : 321-36.

Sorensen J, Kondrup J, Prokopowicz J, Schiesser M, Krahenbuhl L, Meier R et al. EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr. 2008;27 : 340-9.

Borhofen SM, Gerner C, Lehmann J, Fimmers R, Gortzen J, Hey B et al. The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Dig Dis Sci. 2016;61 : 1735-43.

Schutte K, Tippelt B, Schulz C, Rohl FW, Feneberg A, Seidensticker R et al. Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC). Clin Nutr. 2015;34 : 1122-7.

Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology. 2017;65 : 1044-57.

Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21 : 113-7.

Norman K, Kirchner H, Freudenreich M, Ockenga J, Lochs H, Pirlich M. Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease-a randomized controlled trial. Clin Nutr. 2008;27 : 48-56.

Belarmino G, Gonzalez MC, Torrinhas RS, Sala P, Andraus W, D’Albuquerque LA et al. Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis. World J Hepatol. 2017;9 : 401-8.

Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou LQ, Yeh BM et al. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study. Transplantation. 2016;100 : 1692-8.

Dunn MA, Josbeno DA, Tevar AD, Rachakonda V, Ganesh SR, Schmotzer AR et al. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. Am J Gastroenterol. 2016;111 : 1768-75.

Lai J. C. Defining the threshold for too sick for transplant. Curr Opin Organ Transplant. 2016;21 : 127-32.

Sinclair M, Poltavskiy E, Dodge JL, Lai J. C. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist. World J Gastroenterol. 2017;23 : 899-905.

Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10 : 166-73, 73.e1.

Tsien C, Shah SN, McCullough AJ, Dasarathy S. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent. Eur J Gastroenterol Hepatol. 2013;25 : 85-93.

Prado CM, Birdsell LA, Baracos V. E. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care. 2009;3 : 269-75.

Hanai T, Shiraki M, Nishimura K, Imai K, Suetsugu A, Takai K et al. Free fatty acid as a marker of energy malnutrition in liver cirrhosis. Hepatol Res. 2014;44 : 218-28.

Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016;7 : 126-35.

Durand F, Buyse S, Francoz C, Laouenan C, Bruno O, Belghiti J et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60 : 1151-7.

Dasarathy S. Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation. Dig Dis Sci. 2013;58 : 3103-11.

DiMartini A, Cruz RJ, Jr., Dew MA, Myaskovsky L, Goodpaster B, Fox K et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl. 2013;19 : 1172-80.

Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211 : 271-8.

Schneeweiss B, Pammer J, Ratheiser K, Schneider B, Madl C, Kramer L et al. Energy metabolism in acute hepatic failure. Gastroenterology. 1993;105 : 1515-21.

Walsh TS, Wigmore SJ, Hopton P, Richardson R, Lee A. Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med. 2000;28 : 649-54.

Jhangiani SS, Agarwal N, Holmes R, Cayten C, Pitchumoni C. Energy expenditure in chronic alcoholics with and without liver disease. The American journal of clinical nutrition. 1986;44 : 323-9.

Madden AM, Morgan M. Y. Resting energy expenditure should be measured in patients with cirrhosis, not predicted. Hepatology. 1999;30 : 655-64.

Mathur S, Peng S, Gane EJ, McCall JL, Plank L. D. Hypermetabolism predicts reduced transplant-free survival independent of MELD and Child-Pugh scores in liver cirrhosis. Nutrition. 2007;23 : 398-403.

Müller MJ, Böttcher J, Selberg O, Weselmann S, Böker KH, Schwarze M et al. Hypermetabolism in clinically stable patients with liver cirrhosis–. The American journal of clinical nutrition. 1999;69 : 1194-201.

Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller M. J. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology. 1997;25 : 652-7.

Plauth M, Schütz T, Buckendahl DP, Kreymann G, Pirlich M, Grüngreiff S et al. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J Hepatol. 2004;40 : 228-33.

Hipskind P, Glass C, Charlton D, Nowak D, Dasarathy S. Do handheld calorimeters have a role in assessment of nutrition needs in hospitalized patients? A systematic review of literature. Nutr Clin Pract. 2011;26 : 426-33.

Nielsen K, Kondrup J, Martinsen L, Døssing H, Larsson B, Stilling B et al. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr. 1995;74 : 557-67.

Nielsen K, Kondrup J, Martinsen L, Stilling B, Wikman B. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr. 1993;69 : 665-79.

Dolz C, Raurich JM, Ibanez J, Obrador A, Marse P, Gaya J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology. 1991;100 : 738-44.

Weimann A, Braga M, Carli F, Higashiguchi T, Hubner M, Klek S et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017;36 : 623-50.

Tillman EM, Norman JL, Huang EY, Lazar LF, Crill C. M. Evaluation of parenteral nutrition-associated liver disease in infants with necrotizing enterocolitis before and after the implementation of feeding guidelines. Nutr Clin Pract. 2014;29 : 234-7.

Diamond IR, de Silva NT, Tomlinson GA, Pencharz PB, Feldman BM, Moore AM et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enteral Nutr. 2011;35 : 596-602.

Stanko RT, Nathan G, Mendelow H, Adibi S. A. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition. Gastroenterology. 1987;92 : 197-202.

Kelly D. A. Intestinal failure-associated liver disease: what do we know today? Gastroenterology. 2006;130:S70-7.

Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35 : 247-307.

Koletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care. 2010;13 : 321-6.

Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011;60 : 17-25.

Calkins KL, Dunn JC, Shew SB, Reyen L, Farmer DG, Devaskar SU et al. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enteral Nutr. 2014;38 : 682-92.

Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010;34 : 477-84.

Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, O’Loughlin A A et al. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg. 2015;261 : 172-9.

Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014;38 : 693-701.

Sant’Anna AM, Altamimi E, Clause RF, Saab J, Mileski H, Cameron B et al. Implementation of a multidisciplinary team approach and fish oil emulsion administration in the management of infants with short bowel syndrome and parenteral nutrition-associated liver disease. Can J Gastroenterol. 2012;26 : 277-80.

Pichler J, Simchowitz V, Macdonald S, Hill S. Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure. Eur J Clin Nutr. 2014;68 : 1161-7.

Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja H. E. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with omega-6/9 lipid emulsions. JPEN J Parenter Enteral Nutr. 2012;36 : 587-95.

Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010;51 : 514-21.

Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill D. B. Does long-term home parenteral nutrition in adult patients cause chronic liver disease? JPEN J Parenter Enteral Nutr. 1985;9 : 11-7.

Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132 : 525-32.

Burns DL, Gill B. M. Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2013;37 : 274-80.

Venecourt-Jackson E, Hill SJ, Walmsley R. S. Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source. Nutrition. 2013;29 : 356-8.

Xu Z, Li Y, Wang J, Wu B, Li J. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults. Clin Nutr. 2012;31 : 217-23.

Pironi L, Colecchia A, Guidetti M, Belluzzi A, D’Errico A. Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient. European e-Journal of Clinical Nutrition and Metabolism. 2010;5:e243-e6.

Clemmesen JO, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology. 2000;118 : 1131-9.

Vilstrup H, Iversen J, Tygstrup N. Glucoregulation in acute liver failure. Eur J Clin Invest. 1986;16 : 193-7.

Clemmesen JO, Høy C-E, Kondrup J, Ott P. Splanchnic metabolism of fuel substrates in acute liver failure. J Hepatol. 2000;33 : 941-8.

Canbay A, Chen SY, Gieseler RK, Malago M, Karliova M, Gerken G et al. Overweight patients are more susceptible for acute liver failure. Hepatogastroenterology. 2005;52 : 1516-20.

Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29 : 648-53.

Tofteng F, Hauerberg J, Hansen BA, Pedersen CB, Jørgensen L, Larsen F. S. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2006;26 : 21-7.

Reintam Blaser A, Starkopf J, Alhazzani W, Berger MM, Casaer MP, Deane AM et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med. 2017;43 : 380-98.

McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A. S.P. E.N.). JPEN J Parenter Enteral Nutr. 2016;40 : 159-211.

Rabinowich L, Wendon J, Bernal W, Shibolet O. Clinical management of acute liver failure: Results of an international multi-center survey. World J Gastroenterol. 2016;22 : 7595-603.

Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17 : 564-76.

Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr. 1995;19 : 258-65.

Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T et al. VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition. Am J Clin Nutr. 1986;43 : 213-8.

Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B et al. Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids. Gastroenterology. 2016;150 : 903-10.e8.

Koretz R. L. The evidence for the use of nutritional support in liver disease. Curr Opin Gastroenterol. 2014;30 : 208-14.

Anty R, Canivet CM, Patouraux S, Ferrari-Panaia P, Saint-Paul MC, Huet PM et al. Severe Vitamin D Deficiency May be an Additional Cofactor for the Occurrence of Alcoholic Steatohepatitis. Alcohol Clin Exp Res. 2015;39 : 1027-33.

Flannery AH, Adkins DA, Cook A. M. Unpeeling the Evidence for the Banana Bag: Evidence-Based Recommendations for the Management of Alcohol-Associated Vitamin and Electrolyte Deficiencies in the ICU. Crit Care Med. 2016;44 : 1545-52.

Mitchell MC, Friedman LS, McClain C. J. Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017;15 : 5-12.

Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res. 1995;19 : 635-41.

Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos J. T. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol. 1991;86 : 1200-8.

Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol. 1991;86 : 1209-18.

Cabre E, Rodriguez-Iglesias P, Caballeria J, Quer JC, Sanchez-Lombrana JL, Pares A et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology. 2000;32 : 36-42.

Nasrallah SM, Galambos J. T. Aminoacid therapy of alcoholic hepatitis. Lancet. 1980;2 : 1276-7.

Koretz RL, Avenell A, Lipman T. O. Nutritional support for liver disease. Cochrane Database Syst Rev. 2012:Cd008344.

Antar R, Wong P, Ghali P. A meta-analysis of nutritional supplementation for management of hospitalized alcoholic hepatitis. Can J Gastroenterol. 2012;26 : 463-7.

Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud L. L. Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver Int. 2015;35 : 2072-8.

Tsien CD, McCullough AJ, Dasarathy S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012;27 : 430-41.

Kearns PJ, Young H, Garcia G, Blaschke T, O’Hanlon G, Rinki M et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 1992;102 : 200-5.

Keohane PP, Attrill H, Grimble G, Spiller R, Frost P, Silk D. B. Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy. JPEN J Parenter Enteral Nutr. 1983;7 : 346-50.

Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275. J Am Coll Nutr. 1995;14 : 152-8.

Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372 : 1619-28.

Annetta MG, Pittiruti M, Vecchiarelli P, Silvestri D, Caricato A, Antonelli M. Immunonutrients in critically ill patients: an analysis of the most recent literature. Minerva Anestesiol. 2016;82 : 320-31.

Plank LD, Mathur S, Gane EJ, Peng SL, Gillanders LK, McIlroy K et al. Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial. Hepatology. 2015;61 : 639-47.

Plank LD, Gane EJ, Peng S, Muthu C, Mathur S, Gillanders L et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology. 2008;48 : 557-66.

Verboeket-van de Venne WP, Westerterp KR, van Hoek B, Swart G. R. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut. 1995;36 : 110-6.

Achord J. L. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol. 1987;82 : 871-5.

Plauth M, Cabre E, Campillo B, Kondrup J, Marchesini G, Schutz T et al. ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr. 2009;28 : 436-44.

McClave SA, DiBaise JK, Mullin GE, Martindale R. G. ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient. Am J Gastroenterol. 2016;111 : 315-34; quiz 35.

Schafer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F et al. Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest. 2007;37 : 535-43.

Thomas EL, Brynes AE, Hamilton G, Patel N, Spong A, Goldin RD et al. Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol. 2006;12 : 5813-9.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology. 2009;49 : 80-6.

Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004;53 : 413-9.

Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48 : 119-28.

Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51 : 121-9.

Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149 : 367-78.e5; quiz e14-5.

Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring). 2008;16 : 1355-62.

Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD et al. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2017;15 : 96-102.e3.

Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50 : 1105-12.

Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55 : 1738-45.

Zelber-Sagi S, Buch A, Yeshua H, Vaisman N, Webb M, Harari G et al. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol. 2014;20 : 4382-92.

Lin WY, Wu CH, Chu NF, Chang C. J. Efficacy and safety of very-low-calorie diet in Taiwanese: a multicenter randomized, controlled trial. Nutrition. 2009;25 : 1129-36.

Elias MC, Parise ER, de Carvalho L, Szejnfeld D, Netto J. P. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition. 2010;26 : 1094-9.

Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33 : 2156-63.

Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess S. C. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011;93 : 1048-52.

Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin T. L. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care. 2007;30 : 1075-80.

Kirk E, Reeds DN, Finck BN, Mayurranjan MS, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009;136 : 1552-60.

Haufe S, Engeli S, Kast P, Bohnke J, Utz W, Haas V et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology. 2011;53 : 1504-14.

Aller R, de Luis DA, Izaola O, de la Fuente B, Bachiller R. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. Eur Rev Med Pharmacol Sci. 2014;18 : 1041-7.

Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr. 2013;109 : 1096-104.

Markova M, Pivovarova O, Hornemann S, Sucher S, Frahnow T, Wegner K et al. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Gastroenterology. 2017;152 : 571-85.e8.

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64 : 1388-402.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142 : 1592-609.

Wang RT, Koretz RL, Yee HF, Jr. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med. 2003;115 : 554-9.

Barker KB, Palekar NA, Bowers SP, Goldberg JE, Pulcini JP, Harrison S. A. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol. 2006;101 : 368-73.

Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260 : 893-8; discussion 8-9.

Dixon JB, Bhathal PS, O’Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16 : 1278-86.

Harrison SA, Fincke C, Helinski D, Torgerson S, Hayashi P. A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients. Aliment Pharmacol Ther. 2004;20 : 623-8.

Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J et al. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. Gastroenterology. 2015;149 : 379-88; quiz e15-6.

Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15 : 1154-60.

Tendler D, Lin S, Yancy WS, Jr., Mavropoulos J, Sylvestre P, Rockey DC et al. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2007;52 : 589-93.

Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005;100 : 1072-81.

Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2006;4 : 639-44.

Mummadi RR, Kasturi KS, Chennareddygari S, Sood G. K. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6 : 1396-402.

Sasaki A, Nitta H, Otsuka K, Umemura A, Baba S, Obuchi T et al. Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 2014;5 : 164.

Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of clinical investigation. 2009;119 : 1322-34.

Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48 : 993-9.

Volynets V, Machann J, Kuper MA, Maier IB, Spruss A, Konigsrainer A et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52 : 527-35.

Chiu S, Sievenpiper J, De Souza R, Cozma A, Mirrahimi A, Carleton A et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2014;68 : 416.

Chung M, Ma J, Patel K, Berger S, Lau J, Lichtenstein A. H. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis–. The American journal of clinical nutrition. 2014;100 : 833-49.

Misciagna G, Del Pilar Diaz M, Caramia DV, Bonfiglio C, Franco I, Noviello MR et al. Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial. J Nutr Health Aging. 2017;21 : 404-12.

Perez-Guisado J, Munoz-Serrano A. The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study. J Med Food. 2011;14 : 677-80.

Trovato FM, Catalano D, Martines GF, Pace P, Trovato G. M. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr. 2015;34 : 86-8.

Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D et al. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr. 2014;33 : 678-83.

Trovato FM, Martines GF, Brischetto D, Trovato G, Catalano D. Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. World J Hepatol. 2016;8 : 1459-65.

Velasco N, Contreras A, Grassi B. The Mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2014;17 : 453-7.

Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59 : 138-43.

Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137 : 532-40.

Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149 : 389-97.e10.

Mosko JD, Nguyen G. C. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9 : 897-901.

Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL, Jr., Reyes JD et al. Liver transplantation at the extremes of the body mass index. Liver Transpl. 2009;15 : 968-77.

Nair S, Verma S, Thuluvath P. J. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35 : 105-9.

Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology. 2012;56 : 943-51.

Vernon G, Baranova A, Younossi Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34 : 274-85.

Armstrong MJ, Adams LA, Canbay A, Syn W. K. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59 : 1174-97.

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29 : 437-45.

VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ et al. Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease. Gastroenterology. 2017;153 : 1260-72. e3.

Reilly NR, Lebwohl B, Hultcrantz R, Green PH, Ludvigsson J. F. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol. 2015;62 : 1405-11.

Arslan N, Buyukgebiz B, Ozturk Y, Ozer E. The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings. Acta Gastroenterol Belg. 2005;68 : 424-7.

Bardella MT, Fraquelli M, Quatrini M, Molteni N, Bianchi P, Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 1995;22 : 833-6.

Hagander B, Berg NO, Brandt L, Norden A, Sjolund K, Stenstam M. Hepatic injury in adult coeliac disease. Lancet. 1977;2 : 270-2.

Jacobsen MB, Fausa O, Elgjo K, Schrumpf E. Hepatic lesions in adult coeliac disease. Scand J Gastroenterol. 1990;25 : 656-62.

Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Prevalence and clinical importance of hypertransaminasaemia in coeliac disease. Eur J Gastroenterol Hepatol. 1999;11 : 283-8.

Kaukinen K, Halme L, Collin P, Farkkila M, Maki M, Vehmanen P et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 2002;122 : 881-8.

Wakim-Fleming J, Pagadala MR, McCullough AJ, Lopez R, Bennett AE, Barnes DS et al. Prevalence of celiac disease in cirrhosis and outcome of cirrhosis on a gluten free diet: a prospective study. J Hepatol. 2014;61 : 558-63.

Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305 : 1659-68.

Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362 : 1675-85.

Hoofnagle JH, Van Natta ML, Kleiner DE, Clark JM, Kowdley KV, Loomba R et al. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2013;38 : 134-43.

Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O’Moore-Sullivan TM, Lee P et al. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12 : 2092-103.e1-6.

Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y et al. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis. 2015;47 : 226-32.

Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2015;114 : 796-803.

Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014;34 : 837-43.

Guo H, Zhong R, Liu Y, Jiang X, Tang X, Li Z et al. Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. Nutrition. 2014;30 : 198-203.

Zhang PW, Chen FX, Li D, Ling WH, Guo H. H. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease. Medicine (Baltimore). 2015;94:e758.

Farhangi MA, Alipour B, Jafarvand E, Khoshbaten M. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress. Arch Med Res. 2014;45 : 589-95.

Buchman A. L. The addition of choline to parenteral nutrition. Gastroenterology. 2009;137:S119-28.

Guerrerio AL, Colvin RM, Schwartz AK, Molleston JP, Murray KF, Diehl A et al. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. Am J Clin Nutr. 2012;95 : 892-900.

Imajo K, Fujita K, Yoneda M, Shinohara Y, Suzuki K, Mawatari H et al. Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study. Hepatol Res. 2012;42 : 757-66.

Malaguarnera M, Gargante MP, Russo C, Antic T, Vacante M, Malaguarnera M et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial. Am J Gastroenterol. 2010;105 : 1338-45.

Bae JC, Lee WY, Yoon KH, Park JY, Son HS, Han KA et al. Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. Diabetes Care. 2015;38 : 1245-52.

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. Hepatology. 2014;60 : 1211-21.

Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings OW, Chojkier M. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroenterology. 2014;147 : 377-84.e1.

Argo CK, Patrie JT, Lackner C, Henry TD, de Lange EE, Weltman AL et al. Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol. 2015;62 : 190-7.

Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnstrom M, Moris L et al. Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study. Diabetologia. 2018;61 : 1923-34.

Parker HM, Johnson NA, Burdon CA, Cohn JS, O’Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56 : 944-51.

de Castro GS, Calder P. C. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin Nutr. 2018;37 : 37-55.

Musa-Veloso K, Venditti C, Lee HY, Darch M, Floyd S, West S et al. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease. Nutr Rev. 2018;76 : 581-602.

Buss C, Valle-Tovo C, Miozzo S, Alves de Mattos A. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients. Ann Hepatol. 2014;13 : 482-8.

Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D et al. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci. 2011;15 : 1090-5.

Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC et al. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol. 2013;12 : 256-62.

Malaguarnera M, Vacante M, Antic T, Giordano M, Chisari G, Acquaviva R et al. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci. 2012;57 : 545-53.

Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr. 2014;99 : 535-42.

Nabavi S, Rafraf M, Somi MH, Homayouni-Rad A, Asghari-Jafarabadi M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci. 2014;97 : 7386-93.

Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology. 2016;63 : 776-86.

McClave SA, Kushner R, Van Way CW, 3rd, Cave M, DeLegge M, Dibaise J et al. Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations. JPEN J Parenter Enteral Nutr. 2011;35 : 88s-96s.

Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane E. J. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr. 2007;85 : 1257-66.

Prijatmoko D, Strauss BJ, Lambert JR, Sievert W, Stroud DB, Wahlqvist ML et al. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology. 1993;105 : 1839-45.

Selberg O, Böttcher J, Pirlich M, Henkel E, Manns MP, Müller M. J. Clinical significance and correlates of whole body potassium status in patients with liver cirrhosis. Hepatol Res. 1999;16 : 36-48.

Sam J, Nguyen G. C. Protein–calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver International. 2009;29 : 1396-402.

Figueiredo F, Dickson ER, Pasha T, Kasparova P, Therneau T, Malinchoc M et al. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000;70 : 1347-52.

Kalafateli M, Mantzoukis K, Choi Yau Y, Mohammad AO, Arora S, Rodrigues S et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score. J Cachexia Sarcopenia Muscle. 2017;8 : 113-21.

Dharancy S, Lemyze M, Boleslawski E, Neviere R, Declerck N, Canva V et al. Impact of impaired aerobic capacity on liver transplant candidates. Transplantation. 2008;86 : 1077-83.

Pikul J, Sharpe MD, Lowndes R, Ghent C. N. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation. 1994;57 : 469-72.

Owen OE, Reichle FA, Mozzoli MA, Kreulen T, Patel MS, Elfenbein IB et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest. 1981;68 : 240-52.

Owen O, Trapp V, Reichard G, Mozzoli M, Moctezuma J, Paul P et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. The Journal of clinical investigation. 1983;72 : 1821-32.

Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 1994;20 : 119-25.

Müller M, Pirlich M, Balks H, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Clin Chem Lab Med. 1994;32 : 749-58.

Kalaitzakis E, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Jalan R et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver International. 2007;27 : 1194-201.

Cabre E, Abad-Lacruz A, Nunez M, González-Huix F, Fernandez-Banares F, Gil A et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am J Gastroenterol. 1993;88.

Cabre E, Nunez M, Gonzalez-Huin F, Fernandez-Banares F, Abad A, Gil A et al. Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis. Am J Gastroenterol. 1993;88.

Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17 : 445-50.

Harrison J, McKiernan J, Neuberger J. M. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int. 1997;10 : 369-74.

Merli M, Giusto M, Gentili F, Novelli G, Ferretti G, Riggio O et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010;30 : 208-14.

Moukarzel AA, Najm I, Vargas J, McDiarmid SV, Busuttil RW, Ament M. E. Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc. 1990;22 : 1560-3.

Merli M, Giusto M, Lucidi C, Giannelli V, Pentassuglio I, Di Gregorio V et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis. 2013;28 : 281-4.

Iwasa M, Iwata K, Hara N, Hattori A, Ishidome M, Sekoguchi-Fujikawa N et al. Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis. Nutrition. 2013;29 : 1418-21.

Zillikens MC, van den Berg JW, Wattimena JL, Rietveld T, Swart G. R. Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. J Hepatol. 1993;17 : 377-83.

Kondrup J, Muller M. J. Energy and protein requirements of patients with chronic liver disease. J Hepatol. 1997;27 : 239-47.

Dunn MA, Josbeno DA, Schmotzer AR, Tevar AD, DiMartini AF, Landsittel DP et al. The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates. Liver Transpl. 2016;22 : 1324-32.

Lai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study. Hepatology. 2016;63 : 574-80.

Berzigotti A, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54 : 555-61.

Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT et al. Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology. 2009;137 : 549-57.

Berzigotti A, Albillos A, Villanueva C, Genesca J, Ardevol A, Augustin S et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology. 2017;65 : 1293-305.

Tsien C, Davuluri G, Singh D, Allawy A, Ten Have GA, Thapaliya S et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology. 2015;61 : 2018-29.

Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ. 1989;299 : 1202-3.

Kondrup J, Nielsen K, Juul A. Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Br J Nutr. 1997;77 : 197-212.

Bories PN, Campillo B. One-month regular oral nutrition in alcoholic cirrhotic patients. Changes of nutritional status, hepatic function and serum lipid pattern. Br J Nutr. 1994;72 : 937-46.

Campillo B, Bories PN, Pornin B, Devanlay M. Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition. 1997;13 : 613-21.

Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger J. M. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation. 2000;69 : 1364-9.

Manguso F, D’Ambra G, Menchise A, Sollazzo R, D’Agostino L. Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study. Clin Nutr. 2005;24 : 751-9.

Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41 : 38-43.

Ney M, Vandermeer B, van Zanten SJ, Ma MM, Gramlich L, Tandon P. Meta-analysis: oral or enteral nutritional supplementation in cirrhosis. Aliment Pharmacol Ther. 2013;37 : 672-9.

Allard JP, Chau J, Sandokji K, Blendis LM, Wong F. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol. 2001;96 : 2442-7.

Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2016;31 : 1289-94.

Gheorghe L, Iacob R, Vadan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom J Gastroenterol. 2005;14 : 231-8.

Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol. 2016;14 : 454-60.e3; quiz e33.

Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Banares F et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology. 1990;98 : 715-20.

Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015;31 : 193-9.

Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984;4 : 279-87.

Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124 : 1792-801.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3 : 705-13.

Les I, Doval E, Garcia-Martinez R, Planas M, Cardenas G, Gomez P et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study. Am J Gastroenterol. 2011;106 : 1081-8.

Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol. 1990;11 : 92-101.

Plauth M, Egberts EH, Hamster W, Torok M, Muller PH, Brand O et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol. 1993;17 : 308-14.

Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:Cd001939.

Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:Cd001939.

Plauth M, Schutz T. Branched-chain amino acids in liver disease: new aspects of long known phenomena. Curr Opin Clin Nutr Metab Care. 2011;14 : 61-6.

Rossi RE, Conte D, Massironi S. Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues. Dig Liver Dis. 2015;47 : 819-25.

Paternostro R, Wagner D, Reiberger T, Mandorfer M, Schwarzer R, Ferlitsch M et al. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis. Wien Klin Wochenschr. 2017;129 : 8-15.

Garrett-Laster M, Russell RM, Jacques P. F. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Nutr. 1984;38 : 203-14.

Weismann K, Christensen E, Dreyer V. Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med Scand. 1979;205 : 361-6.

Grungreiff K, Abicht K, Kluge M, Presser HJ, Franke D, Kleine FD et al. Clinical studies on zinc in chronic liver diseases. Z Gastroenterol. 1988;26 : 409-15.

Van der Rijt CC, Schalm SW, Schat H, Foeken K, De Jong G. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology. 1991;100 : 1114-8.

Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med. 1993;2 : 414-6.

Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet. 1984;2 : 493-5.

Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991;36 : 1204-8.

Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23 : 1084-92.

Gu XB, Yang XJ, Zhu HY, Xu B. Y. Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis. Gut Liver. 2012;6 : 355-61.

Morando F, Rosi S, Gola E, Nardi M, Piano S, Fasolato S et al. Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2015;35 : 1508-15.

Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O et al. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis. J Gastroenterol Hepatol. 2012;27 : 813-22.

Dupont B, Dao T, Joubert C, Dupont-Lucas C, Gloro R, Nguyen-Khac E et al. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Aliment Pharmacol Ther. 2012;35 : 1166-74.

de Ledinghen V, Beau P, Mannant PR, Borderie C, Ripault MP, Silvain C et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci. 1997;42 : 536-41.

Vilstrup H, Gluud C, Hardt F, Kristensen M, Kohler O, Melgaard B et al. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J Hepatol. 1990;10 : 291-6.

Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier JM, Gauthier AP et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology. 1983;3 : 475-80.

Naylor CD, O’Rourke K, Detsky AS, Baker J. P. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology. 1989;97 : 1033-42.

Calvey H, Davis M, Williams R. Prospective study of nasogastric feeding via East Grinstead or Viomedex tubes compared with oral dietary supplementation in patients with cirrhosis. Clin Nutr. 1984;3 : 63-6.

Loser C, Aschl G, Hebuterne X, Mathus-Vliegen EM, Muscaritoli M, Niv Y et al. ESPEN guidelines on artificial enteral nutrition-percutaneous endoscopic gastrostomy (PEG). Clin Nutr. 2005;24 : 848-61.

Baltz JG, Argo CK, Al-Osaimi AM, Northup P. G. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointest Endosc. 2010;72 : 1072-5.

Garrison RN, Cryer HM, Howard DA, Polk HC, Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199 : 648-55.

Merli M, Nicolini G, Angeloni S, Riggio O. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition. 2002;18 : 978-86.

Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant. 2003;17 : 401-11.

Shaw BW, Jr., Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl T. E. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis. 1985;5 : 385-93.

Shepherd RW, Chin SE, Cleghorn GJ, Patrick M, Ong TH, Lynch SV et al. Malnutrition in children with chronic liver disease accepted for liver transplantation: clinical profile and effect on outcome. J Paediatr Child Health. 1991;27 : 295-9.

Ney M, Abraldes JG, Ma M, Belland D, Harvey A, Robbins S et al. Insufficient protein intake is associated with increased mortality in 630 patients with cirrhosis awaiting liver transplantation. Nutr Clin Pract. 2015;30 : 530-6.

Plank LD, McCall JL, Gane EJ, Rafique M, Gillanders LK, McIlroy K et al. Pre-and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin Nutr. 2005;24 : 288-96.

Coolsen MM, Wong‐Lun‐Hing EM, van Dam RM, van der Wilt AA, Slim K, Lassen K et al. A systematic review of outcomes in patients undergoing liver surgery in an enhanced recovery after surgery pathways. HPB (Oxford). 2013;15 : 245-51.

Hughes MJ, McNally S, Wigmore S. J. Enhanced recovery following liver surgery: a systematic review and meta‐analysis. HPB (Oxford). 2014;16 : 699-706.

Leonard J, Heimbach J, Malinchoc M, Watt K, Charlton M. The impact of obesity on long‐term outcomes in liver transplant recipients—results of the NIDDK liver transplant database. Am J Transplant. 2008;8 : 667-72.

Grąt M, Wronka KM, Lewandowski Z, Grąt K, Krasnodębski M, Stypułkowski J et al. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36 : 1530-9.

Kaido T, Mori A, Ogura Y, Ogawa K, Hata K, Yoshizawa A et al. Pre- and perioperative factors affecting infection after living donor liver transplantation. Nutrition. 2012;28 : 1104-8.

Kaido T, Mori A, Oike F, Mizumoto M, Ogura Y, Hata K et al. Impact of pretransplant nutritional status in patients undergoing liver transplantation. Hepatogastroenterology. 2010;57 : 1489-92.

Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J et al. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl. 2011;17 : 1073-80.

Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr. 1992;56 : 158-63.

Singer P, Cohen J, Cynober L. Effect of nutritional state of brain-dead organ donor on transplantation. Nutrition. 2001;17 : 948-52.

Plank LD, Metzger DJ, McCall JL, Barclay KL, Gane EJ, Streat SJ et al. Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery. Ann Surg. 2001;234 : 245-55.

Hussaini SH, Oldroyd B, Stewart SP, Soo S, Roman F, Smith MA et al. Effects of orthotopic liver transplantation on body composition. Liver. 1998;18 : 173-9.

Selberg O, Burchert W, Vd Hoff J, Meyer GJ, Hundeshagen H, Radoch E et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. The Journal of clinical investigation. 1993;91 : 1897-902.

Tietge UJ, Selberg O, Kreter A, Bahr MJ, Pirlich M, Burchert W et al. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Liver Transpl. 2004;10 : 1030-40.

Schutz T, Hudjetz H, Roske AE, Katzorke C, Kreymann G, Budde K et al. Weight gain in long-term survivors of kidney or liver transplantation-another paradigm of sarcopenic obesity? Nutrition. 2012;28 : 378-83.

Roman E, Torrades MT, Nadal MJ, Cardenas G, Nieto JC, Vidal S et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59 : 1966-75.

Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Paul SM, Dodd MJ et al. A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant. 2006;6 : 1896-905.

Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E et al. Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr. 1995;19 : 437-43.

Wicks C, Somasundaram S, Bjarnason I, Menzies IS, Routley D, Potter D et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet. 1994;344 : 837-40.

Plevak DJ, DiCecco SR, Wiesner RH, Porayko MK, Wahlstrom HE, Janzow DJ et al. Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clin Proc. 1994;69 : 225-30.

Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg. 2011;201 : 498-502.

Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74 : 123-7.

Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant. 2005;5 : 125-30.

Zhang Y, Chen J, Wu J, Chalson H, Merigan L, Mitchell A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary surgery and nutrition. 2013;2 : 142.

Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Ninomiya M, Uchiyama H et al. Bacterial sepsis after living donor liver transplantation: the impact of early enteral nutrition. J Am Coll Surg. 2012;214 : 288-95.

Kim JM, Joh JW, Kim HJ, Kim SH, Rha M, Sinn DH et al. Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study. Medicine (Baltimore). 2015;94:e1771.

Sawas T, Al Halabi S, Hernaez R, Carey WD, Cho W. K. Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2015;13 : 1567-74.e3; quiz e143-4.

Reilly J, Mehta R, Teperman L, Cemaj S, Tzakis A, Yanaga K et al. Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr. 1990;14 : 386-91.

Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331 : 1547-52.

Hu QG, Zheng Q. C. The influence of Enteral Nutrition in postoperative patients with poor liver function. World J Gastroenterol. 2003;9 : 843-6.

##submission.downloads##

Опубліковано

2021-03-22

Номер

Розділ

Стандарти діагностики та лікування